Mikaela Naylon Give Kids a Chance Act

This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.

Learn about this bill’s status and read its full summary in the Pocket Congress app.